https://www.selleckchem.com/pr....oducts/1-4-diaminobu
01; 95% confidence interval 0.83-1.23; P= .952). Subgroup analysis for associations between duration of LTRA use and risk of NP disease indicated no significance for all groups (6, 6 to 12, 12 to 24, and ≥24 months). Common NP diseases included dementia (75.4% vs 76.1%), mood disorders (12.68% vs 12.80%), and panic disorders (5.63% vs 3.53%) in LTRA users and non-LTRA users, respectively, and there was no significant difference in the prevalence of each NP disease in either group. The current study
Like
Comment
Share
